Clinical Trials Browser

Small Cell Lung Cancer Limited Stage × toripalimab × 90 days × Clear all

NCT04418648 2026-02-04

Study of Toripalimab for Limited-Stage Small Cell Lung Cancer Following Concurrent Chemoradiotherapy

Phase 2 Terminated

Small Cell Lung Cancer Limited Stage